"RT or not RT?" The question for early-stage peripheral T-cell lymphoma.

doi:10.1080/10428194.2021.1876873

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

"RT or not RT?" The question for early-stage peripheral T-cell lymphoma.

Leukemia & lymphoma - 1 Mar 2021

Campbell Belinda A, Khot Amit

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Chemoradiotherapy
Share to Lymphoma, T-Cell, Peripheral
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Open in PubMed

Identifiers

PMID: 33509008
DOI: 10.1080/10428194.2021.1876873

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

"RT or not RT?" The question for early-stage peripheral T-cell lymphoma.PMID 33509008Read ↗

[Recent advance in peripheral T-cell lymphoma, not otherwise specified].Semantic proximity Read ↗

Cure for CLL?Semantic proximity Read ↗

Treatment selection and survival outcomes in Early-Stage peripheral T-Cell lymphomas: does anaplastic lymphoma kinase mutation impact the benefit of consolidative radiotherapy?Semantic proximity Read ↗

Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphomaSemantic proximity Read ↗

Ask the doctor. My father had lymphoma and my mother had colon cancer. Does that mean I'll get cancer, too?Semantic proximity Read ↗

G-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphomaSemantic proximity Read ↗

First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantationSemantic proximity Read ↗

Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.